Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -410,108 | -297,174 | -193,103 | -102,974 | -290,073 |
| Depreciation Amortization | 15,130 | 12,112 | 8,612 | 4,601 | 19,050 |
| Accounts receivable | -15,036 | -6,848 | -1,216 | -516 | 31,639 |
| Accounts payable and accrued liabilities | 10,098 | -1,462 | -3,590 | 347 | 1,676 |
| Other Working Capital | 17,219 | 6,435 | -3,304 | -3,905 | 35,116 |
| Other Operating Activity | 74,996 | 57,573 | 38,773 | 18,824 | 13,452 |
| Operating Cash Flow | $-307,701 | $-229,364 | $-153,828 | $-83,623 | $-189,140 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 357,148 | 236,878 | 247,985 | 129,756 | -306,900 |
| PPE Investments | -64,557 | -44,678 | -24,380 | -2,759 | -12,950 |
| Purchase Of Investment | -150,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -150,000 | -150,000 | -9,057 | -1,471 |
| Investing Cash Flow | $142,591 | $42,200 | $73,605 | $117,940 | $-321,321 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 150,000 | 150,000 | 150,000 | N/A | N/A |
| Common Stock Issued | 28,428 | 24,991 | 20,567 | 16,125 | 616,555 |
| Common Stock Repurchased | -596 | -241 | -163 | -59 | -378 |
| Financing Cash Flow | $177,832 | $174,750 | $170,404 | $16,066 | $616,177 |
| Beginning Cash Position | 182,366 | 180,895 | 180,895 | 180,895 | 75,179 |
| End Cash Position | 195,088 | 168,481 | 271,076 | 231,278 | 180,895 |
| Net Cash Flow | $12,722 | $-12,414 | $90,181 | $50,383 | $105,716 |
| Free Cash Flow | |||||
| Operating Cash Flow | -307,701 | -229,364 | -153,828 | -83,623 | -189,140 |
| Capital Expenditure | -64,557 | -44,678 | -24,380 | -2,759 | -12,950 |
| Free Cash Flow | -372,258 | -274,042 | -178,208 | -86,382 | -202,090 |